Share-Based Compensation and Other Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summary of Changes in Nonvested Restricted Stock Awards

A summary of changes in our unvested shares follows:

	Years Ended December 31,
	2023		2022
(shares in thousands)	Shares	Weighted Average Grant-Date Fair Value	Shares	Weighted Average Grant-Date Fair Value
Unvested balance at beginning of period	1,869	$17.76	554	$16.16
Granted during the year	1,042	15.43	1,916	18.12
Vested during the year	(924)	17.80	(453)	17.29
Forfeited during the year	(55)	16.84	(148)	17.88
Unvested balance at end of period	1,932	$16.51	1,869	$17.76

Summary of Changes in Nonvested Restricted Shares

A summary of changes in our unvested shares follows:

	Years Ended December 31,
	2023		2022
(shares in thousands)	Shares	Weighted Average Grant-Date Fair Value	Shares	Weighted Average Grant-Date Fair Value
Unvested balance at beginning of period	2,081	$17.23	886	$14.80
Granted during the year	355	18.01	1,935	17.66
Vested during the year	(1,286)	16.29	(720)	15.41
Forfeited during the year	(8)	17.82	(73)	16.73
Dividend equivalents adjustment	35	17.21	53	16.82
Unvested balance at end of period	1,177	$17.50	2,081	$17.23

Schedule of Information Related to Stock Option Plan

Information related to stock option and appreciation rights follows:

	Year Ended December 31,
(dollars in thousands)	2023		2022		2021
Intrinsic value of options/appreciation rights exercised	$	70	$	331	$	171
Tax benefit realized from options/appreciation rights exercises	28		132		68